Karen Lynch, a superstar CEO championing the biggest of big ideas, is out. As chief of corner drugstore and health insurance colossus CVS, Lynch headed the largest Fortune 500 enterprise, measured ...

CVS Health CEO Karen Lynch has stepped down, with company shares sinking 19% this year. CVS Health also warned of disappointing third-quarter earnings.

Karen Lynch took over CVS with a story of trauma and loss. Her ouster is another twist. Lynch’s plan to turn the pharmacy giant into a central touchpoint for customers’ health needs will ...

CVS shares dropped on Friday as it replaced CEO Karen Lynch, who took over in 2021. AP. They are down by nearly half from their 2022 highs, in part due to quarter after quarter of repeated profit ...

CVS Health abruptly ousted its chief executive, Karen S. Lynch, on Friday as the pharmacy and health care conglomerate struggled with sluggish growth and faced pressure from investors.

CVS Health announced Friday that David Joyner has been appointed President and Chief Executive Officer, effective as of Oct.

- Out of office. For three years in a row, Karen Lynch was ranked No. 1 on Fortune's Most Powerful Women list. Her job as CEO of CVS Health earned her that title, and she earned the company one as ...

Former CVS CEO Karen Lynch, replaced by David Joyner, often spoke about how her family history motivated her efforts to change health care. Skip to Main Content. Manage alerts for this article; ...

CVS once again lowered its guidance for the year, and the company now expects to bring in between $4.95 and $5.20 in earnings per share. That's down from a previous projection of at least $5.64.